Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current information on nida.nih.gov.

Substance abuse is associated with a wide spectrum of medical disorders, including infections due to the human immunodeficiency virus (HIV) and the hepatitis C virus (HCV) as well as sexually transmitted infections. Despite the seriousness of this problem, there has not been a systematic investigation of infectious disease services in the substance abuse treatment health care delivery system. This study surveyed CTP administrators and direct care providers, and reviews policies related to clinical guidelines and reimbursement through a survey of administrators of state substance abuse agencies or health departments.

CTN Protocol ID: 
CTN-0012
DSMB ID: 
DSMB-0012

Principal Investigator(s)

Lawrence S. Brown, Jr., M.D., M.P.H., FASAM
lbrown@artcny.org